outpatient visits. That care model falls short not just because it is expensive and often fails to proactively improve health, but also because so much of health is explained by individual behaviors, 1 most of which occur outside health care encounters. Indeed, even patients with chronic illness might spend only a few hours a year with a doctor or nurse, but they spend 5000 waking hours each year engaged in everything else -including deciding whether to take prescribed medications or follow other medical advice, deciding what to eat and drink and whether to smoke, and making other choices about activities that can profoundly affect their health.
The increasing attention being paid to those 5000 hours takes various forms. Employers are focusing more on employees' wellness -how they eat, whether they smoke, and how much they exercise. Medication adherence has become a more important goal, thanks to growing recognition that many people with chronic conditions fail to take their medications regularly and therefore do not get the benefits that health care can provide. Home-based biometric assessments of indicators such as glucose level, blood pressure, and weight are emerging as part of longitudinal clinical care. Transitional care models are being touted as a way of coordinating care beyond hospitalization. And hospitals and health plans are developing "hot-spotter" approaches, deploying tailored and intensive attention to managing the care of their most challenging patients. 2 All these activities occur outside the conventional, billable, clinical encounter -and all reflect some sort of hovering over people in their daily lives.
Conventional approaches to improving patient engagement along these dimensions have been personnel-intensive -using visiting nurses or clinically staffed telemedicine services. Although results have been mixed, in general these programs have not fulfilled their promise. One problem is that using personnel in hovering is expensive and therefore diffi- T he dominant form of health care financing in the United States supports a reactive, visitbased model in which patients are seen when they become ill, typically during hospitalizations and at cult to scale up and to justify, except for the very sickest patients, some of whom might be too sick to benefit. Another problem is that initiating and maintaining patient engagement is difficult. A large multicenter trial of telemonitoring for patients with heart failure showed no effect on the primary outcomes of rehospitalization and death; moreover, 14% of those assigned to the intervention group would not use the system at all, and nearly half of those who did lost interest over time. One challenge, therefore, is finding a way to automate hovering to reduce its cost. A related challenge is figuring out how to incorporate it into people's lives in ways that are not just acceptable and convenient, but ideally even welcomed.
Three recent developments suggest that automated hovering may offer promise. First are early efforts at payment mechanisms that support more accountability for health outcomes -including nonreimbursement for preventable readmissions and bundling of payments around the goals of care rather than encounters. These changes provide a financial engine to support automated hovering initiatives.
The second development is our deepening understanding of behavioral economics and the reality that although most people want better health and typically know what it would take to achieve it, the desires, distractions, and urgencies of the moment often get in the way of pursuing what's in their own long-term self-interest. Behavioral economics explains why people are predictably irrational and provides tools for redirecting their behavior with carefully deployed nudges and financial incentives. 3 The third development is the expanded reach of both sophisticated and simple technologiescell phones, wireless devices, and the Internet -that can help health experts connect to people during their everyday lives. Neither wireless devices nor behavioral economics were part of the disease-management programs that have produced mixed results in the past.
There is already considerable evidence of the promise of automated hovering. One study of patients taking warfarin deployed a home-based pill dispenser that was electronically tethered to a lottery system. Patients were automatically entered into a daily random drawing, with a small chance of winning $100 and a larger chance of winning $10. Each day, patients were electronically notified if their number had come up -which it would do about 1 day in 5 -but were eligible for the prize only if they had taken their warfarin the previous day, as signaled by the dispenser. The system provided daily engagement, the chance of a prize, and a sense of anticipated regret: no one wants to receive news of winning only to be disqualified for nonadherence the previous day. The expected value of the lottery was less than $3 per day, but the system reduced the rate of incorrect doses from 22% to about 3% and reduced the rate of out-of-range international normalized ratios from 35% to 12%. 4 Such a system could easily be deployed to improve medication adherence among patients discharged from the hospital with congestive heart failure or after being treated for acute coronary syndromes. This system uses technology with an engagement strategy informed by behavioral economics to hover over patients.
In another clinical trial, patients with difficult-to-control diabetes were randomly assigned to receive usual care or mentorship from another patient who had previously managed to tame his or her own diabetes. The mentor merely had to call the patient once a week. The result at 6 months was glycated hemoglobin levels more than a full percentage point lower than those in the control group, created by a system requiring minimal technology to produce hovering that was "automatic" from the clinician's perspective. 5 This kind of hovering must be targeted to the right clinical and social circumstances. The biggest savings will probably come from reducing preventable hospitalizations or delaying entrance into nursing homes, because that's where so much spending currently occurs. However, cell-phone mentors and automatic pill-bottle reminders probably won't offer much to patients who are frequently hospitalized owing to a combination of severe illness and challenging life circumstances. These patients, at one end of the spectrum of intensity of health care needs, require a more personnel-intensive approach that focuses as much on social circumstances as on complex medical care. The best targets for automated hovering are conditions whose management depends substantially on individual patients' behavior. Good targets are medication adherence in patients with heart failure or acute coronary syndromes and efforts to manage diet, exercise, or weight. The amount of hovering required to engage patients in healthy behaviors during those 5000 hours will depend critically on the intensity of their needs, but automated systems might be a cost-effective solution for many patients.
There are potential concerns. Some people might worry that too much hovering will erode patients' sense of personal responsibility or that hovering in one area might distract providers or patients from other important health issues. Others may worry that hovering is too intrusive or paternalistic -though patients could easily opt out, and it's arguably no more paternalistic than traditional approaches to improving patient outcomes. It will be important to ensure that new hovering efforts are evaluated carefully, with assessment of both intended and potential unintended consequences.
And of course, there is a considerable amount we don't know about these approaches: the kinds of patients, conditions, or settings for which they will be the most useful; the organizations (hospitals, employers, or insurers) that should be the ones to deploy them; and how to make them heard over the din of everything else that competes for attention while remaining unintrusive enough that nudges don't become self-defeating nags. There are both clinical and research opportunities in pursuing an approach that is just as rigorous as our approach to other areas of medicine. Careful iterative testing is essential because these new forms of patient engagement, whatever shape they take, will be central to improving population health in our future health care system.
